07 September 2010
 Your Basket
Your basket is currently empty.
 Your Account
« Your Profile »
« Order History »
 Options
Add this Report to your shopping basket
View Report's Table of Contents
 FEATURED REPORT

 OTC Pharmaceuticals & Pharmacy Retailing in China 2010: A Market Analysis
Updated - July 9, 2010
DESCRIPTION
This report covers the retail market for western drugs, traditional Chinese medicines, vitamins, minerals & supplements, and other pharmaceutical products sold through the retail channel in China, and the drugstore market.
PRICE
£1,000
EXTRACT FROM INTRODUCTION
'...China has a large and fast-growing OTC pharmaceuticals industry. The total OTC pharmaceuticals retail market increased to RMB72.02bn in 2009, and the market is expected to surpass RMB100bn by 2013. Retail sales value of OTC drugs expanded by 102% between 2003 and 2009.

Increasing public awareness about health care and the importance of self-medication as well as the rapid rise in urban living standards and growing disposable income levels are combining to allow for the increased purchase of OTC pharmaceuticals and consequently propelling growth in the market.

China¡¯s USD 124bn healthcare reform, announced in April 2009, will boost demand for pharmaceutical products ranging from generic drugs to medical equipment. The long-term implication of the healthcare reform on the OTC pharmaceuticals retail market and the pharmacy retailing market is still too early to tell.

However, anecdotal evidence has suggested a 40-60% decline in store traffic in some of the drugstores located in places that have implemented the healthcare reform. As part of the healthcare reform, essential drugs are to be sold at government hospitals at wholesale prices.

Drugstores will benefit immensely from the healthcare reform only when there is a clear separation of drug dispensing and prescribing. In the meantime, drugstores are looking at ways to improve their thinning margins. Some have turned to the internet and some to private label. Most of them are now selling other non-pharmaceutical products such as personal care, family care and convenience products.

The weakness of retail prices, caused by intense competition, continues to put pressure on retailer¡¯s margins, forcing them to consolidate further.

Consolidation is being hampered by the low barrier of entry into this sector. As it is easy for new entrants to come into the market, the country is seeing an oversupply of drugstores. In Guangzhou alone, there is one drugstore for every 1,500 people. As the market share of the top 10 drugstore chains remains low, no chains will be dominating the pharmacy market for the foreseeable future.

In 2009, the drugs retail market stood at RMB136bn, up 119% over 2003. The drugs retail market is expected to grow by 56% in constant value terms between 2010 and 2015. ...'
Email Report Summary to a Friend       View Printer-Friendly version of this page


 Search Reports
Keywords: 
Advanced Search        
 Latest News
Good Looking Blokes...more
Cash for the Media...more
Flat Panel is the Future...more
Pay-For-Football...more
White Collar Unemployment...more
Access Asia Privacy Policy
Access Asia: Registered Office - 130 Aztec, Aztec West, Bristol BS32 4UB, United Kingdom
Tel: +44-20-8123-2020
Access Asia: China Office - Office 509, Shenxin Mansions, 200, Ninghai East Road, Shanghai 200021, PR China
Tel: +86 (0)21-6374-7484 or (0)21-6374-5679 Fax: +86 (0)21-6374-7483
Access Asia: Malaysia Office - Suite C-08-03, Block C, Plaza Mont Kiara, 2 Jalan Kiara, Mont Kiara, 50480 Kuala Lumpur, Malaysia
Tel: +60 (0)3-6203-5212 Fax: +60 (0)3-6203-9212
This site and contents ©2000/2003 Access Asia Ltd., a company registered in England no. 03493552
Site design and layout ©2000/2003 The Software House
Note: Any refunds on purchases made through our web site are at the sole discretion of the Access Asia management.